594
Views
22
CrossRef citations to date
0
Altmetric
Review article

Cangrelor: an emerging therapeutic option for patients with coronary artery disease

, , , , , , , , & show all
Pages 813-828 | Accepted 31 Dec 2013, Published online: 24 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Piotr Adamski, Urszula Adamska, Małgorzata Ostrowska, Eliano Pio Navarese & Jacek Kubica. (2018) Evaluating current and emerging antithrombotic therapy currently available for the treatment of acute coronary syndrome in geriatric populations. Expert Opinion on Pharmacotherapy 19:13, pages 1415-1425.
Read now
Udaya Tantry, Rahul Chaudhary, Jacek Kubica, Kevin Bliden & Paul A Gurbel. (2018) Cangrelor for the treatment of patients with Arterial Thrombosis. Expert Opinion on Pharmacotherapy 19:12, pages 1389-1398.
Read now
Piotr Adamski, Urszula Adamska, Małgorzata Ostrowska, Marek Koziński & Jacek Kubica. (2016) New directions for pharmacotherapy in the treatment of acute coronary syndrome. Expert Opinion on Pharmacotherapy 17:17, pages 2291-2306.
Read now

Articles from other publishers (19)

Muhammad Abubakar, Saud Raza, Khawaja Mushammar Hassan, Izzah Javed, Khawaja Momal Hassan, Fiza Farrukh, Khawaja Muthammir Hassan & Muhammad Ahmad Faraz. (2023) Efficacy, Safety, and Role of Antiplatelet Drugs in the Management of Acute Coronary Syndrome: A Comprehensive Review of Literature. Cureus.
Crossref
Kris Kumar & Harsh Golwala. (2022) Antiplatelet Agents in Acute ST Elevation Myocardial Infarction. The American Journal of Medicine 135:6, pages 697-708.
Crossref
Abdul A. Khan, Ghulam Murtaza, Muhammad Khalid, Mathew Finniss & Thomas Helton. (2020) Efficacy of Cangrelor as Bridging Therapy Post PCI. Cardiovascular & Hematological Disorders-Drug Targets 20:3, pages 227-231.
Crossref
Neeraj Sinha, Galit Balayla & Joao Braghiroli. (2020) Coronary artery disease in lung transplant patients. Clinical Transplantation 34:11.
Crossref
Aamer Ahmed & Adeel Majeed. 2019. Patient Blood Management in Cardiac Surgery. Patient Blood Management in Cardiac Surgery 51 60 .
Udaya S. Tantry, Eliano P. Navarese, Aung Myat & Paul A. Gurbel. (2018) Selection of P2Y 12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome. Progress in Cardiovascular Diseases 60:4-5, pages 460-470.
Crossref
Simon Hennink-Schadenberg & Benedikt Preckel. 2018. Anesthesia in High-Risk Patients. Anesthesia in High-Risk Patients 3 17 .
Piotr Adamski, Joanna Sikora, Ewa Laskowska, Katarzyna Buszko, Małgorzata Ostrowska, Julia M. Umińska, Adam Sikora, Natalia Skibińska, Przemysław Sobczak, Urszula Adamska, Danuta Rość, Aldona Kubica, Przemysław Paciorek, Michał P. Marszałł, Eliano P. Navarese, Diana A. Gorog & Jacek Kubica. (2017) Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study. PLOS ONE 12:10, pages e0186013.
Crossref
Piotr Adamski, Małgorzata Ostrowska, Joanna Sikora, Karolina Obońska, Katarzyna Buszko, Magdalena Krintus, Grażyna Sypniewska, Michał Piotr Marszałł, Marek Koziński & Jacek Kubica. (2017) Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study. BMJ Open 7:4, pages e013218.
Crossref
Jolanta M. Siller-Matula, Simon Specht, Jacek Kubica, Dimitrios Alexopoulos, Raffaele De Caterina, Eva-Luise Hobl, Bernd Jilma, Günter Christ & Irene M. Lang. (2016) Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients. British Journal of Clinical Pharmacology 82:5, pages 1343-1350.
Crossref
Ana Lucrecia Marcano & José Luis Ferreiro. (2016) Role of New Antiplatelet Drugs on Cardiovascular Disease: Update on Cangrelor. Current Atherosclerosis Reports 18:11.
Crossref
Jacek Kubica, Aldona Kubica, Bernd Jilma, Piotr Adamski, Eva-Luise Hobl, Eliano Pio Navarese, Jolanta Maria Siller-Matula, Anita Dąbrowska, Tomasz Fabiszak, Marek Koziński & Paul Alfred Gurbel. (2016) Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors. International Journal of Cardiology 215, pages 201-208.
Crossref
Zhen Zhang, Guanzhong Wu, Chengqian Wang, Xiao Jin, Dong Li & Kejiang Lin. (2016) Features of reversible P2Y12 receptor antagonists based on piperazinyl-glutamate-pyridines. Medicinal Chemistry Research 25:6, pages 1204-1215.
Crossref
Nixiao Zhang, Kangyin Chen, Seung-Woon Rha, Guangping Li & Tong Liu. (2016) Morphine in the setting of acute myocardial infarction: pros and cons. The American Journal of Emergency Medicine 34:4, pages 746-748.
Crossref
Megan M. Shifrin & S. Brian Widmar. (2016) Platelet Inhibitors. Nursing Clinics of North America 51:1, pages 29-43.
Crossref
Jacek Kubica, Piotr Adamski, Małgorzata Ostrowska, Joanna Sikora, Julia Maria Kubica, Wiktor Dariusz Sroka, Katarzyna Stankowska, Katarzyna Buszko, Eliano Pio Navarese, Bernd Jilma, Jolanta Maria Siller-Matula, Michał Piotr Marszałł, Danuta Rość & Marek Koziński. (2016) Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial. European Heart Journal 37:3, pages 245-252.
Crossref
Rahil Rafeedheen, Kevin P. Bliden, Fang Liu, Udaya S. Tantry & Paul A. Gurbel. (2015) Novel Antiplatelet Agents in Cardiovascular Medicine. Current Treatment Options in Cardiovascular Medicine 17:6.
Crossref
Jolanta M. Siller-Matula, Carina Gruber, Marcel Francesconi, Cornelia Dechant, Bernd Jilma, Georg Delle-Karth, Katharina Grohs, Andrea Podczeck-Schweighofer & Günter Christ. (2014) The net clinical benefit of personalized antiplatelet therapy in patients undergoing percutaneous coronary intervention. Clinical Science 128:2, pages 121-130.
Crossref
Piotr Adamski, Marek Koziński, Małgorzata Ostrowska, Tomasz Fabiszak, Eliano Navarese, Przemysław Paciorek, Grzegorz Grześk & Jacek Kubica. (2017) Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors. Thrombosis and Haemostasis 112:08, pages 224-242.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.